{"id":"W4309319190","doi":"10.25251/skin.6.supp.65","title":"Bimekizumab maintenance of response through three years in patients with moderate to severe plaque psoriasis who responded at Week 16: Results from the BE BRIGHT open-label extension trial","year":2022,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Plaque psoriasis; Open label; Psoriasis; Medicine; Extension (predicate logic); Internal medicine; Dermatology; Randomized controlled trial; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002416549,0.0009781539,0.002839053,0.0002767298,0.0005143633,0.001432557,0.0007069427,0.001449994,0.003474451],"category_scores_gemma":[0.001495575,0.0004543848,0.002210778,0.0003312202,0.0009628559,0.001322564,0.0004185027,0.003652273,0.0009660219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007391506,"about_ca_system_score_gemma":0.0007841285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009907259,"about_ca_topic_score_gemma":0.001531113,"domain_scores_codex":[0.9991602,0.000350082,0.00004127884,0.0001297982,0.00006729308,0.0002513251],"domain_scores_gemma":[0.9988979,0.0002519581,0.0002495603,0.0001203178,0.00005942253,0.000420724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9536269,0.00564028,0.002473471,0.0004375206,0.0009534854,0.0000698619,0.0001070962,0.0004149953,0.003809178,0.0001070655,0.001740226,0.03061987],"study_design_scores_gemma":[0.8473875,0.129609,0.01896992,0.00007905196,0.001006229,0.0001204893,0.00007321116,0.0005126723,0.0006239325,0.0002539839,0.001329324,0.00003460546],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918398,0.004134703,0.0002498624,0.0006161982,0.000212144,0.000450465,0.0007307249,0.00006078115,0.001705457],"genre_scores_gemma":[0.99371,0.001426367,0.0003895239,0.0008174499,0.0002602687,0.0005928777,0.0008301335,0.00001979399,0.001953484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003474451,"threshold_uncertainty_score":0.01278007,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02902341705181288,"score_gpt":0.2578144856618625,"score_spread":0.2287910686100496,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}